Cargando…
Revealing the anticancer potential of candidate drugs in vivo using Caenorhabditis elegans mutant strains
Drug repurposing is used as a strategy for finding new drugs for cancer. The process is a faster and a more cost-effective way of providing new indications for drugs that can address emerging drug resistance and numerous side effects of chemotherapeutic drugs. In this study, the in vivo anticancer p...
Autores principales: | Medina, Paul Mark, Ponce, Jozelle Marie, Cruz, Christian Alfredo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689339/ https://www.ncbi.nlm.nih.gov/pubmed/33221682 http://dx.doi.org/10.1016/j.tranon.2020.100940 |
Ejemplares similares
-
Genomic sequence of a mutant strain of Caenorhabditis elegans with an altered recombination pattern
por: Rose, Ann M, et al.
Publicado: (2010) -
A Multimodal Genotoxic Anticancer Drug Characterized by Pharmacogenetic Analysis in Caenorhabditis elegans
por: Ye, Frank B., et al.
Publicado: (2020) -
In Vivo Imaging of Caenorhabditis elegans Glycans
por: Laughlin, Scott T., et al.
Publicado: (2009) -
The alteration of myosin isoform compartmentation in specific mutants of Caenorhabditis elegans
Publicado: (1986) -
Caenorhabditis elegans
daf-7 mutants exhibit burrowing behavior
por: López-Puebla, Araceli, et al.
Publicado: (2019)